Bolivia, Plurinational State of vs Eritrea: Average cost of multi drug-resistant tuberculosis treatment
Bolivia, Plurinational State of
753 constant 2022 US$
in 2024
Eritrea
793 constant 2022 US$
in 2024
Bolivia, Plurinational State of rank
65th
Eritrea rank
62nd
Average cost of multi drug-resistant tuberculosis treatment over time
- Bolivia, Plurinational State of
- Eritrea
How they compare
Eritrea currently reports 793 constant 2022 US$ against 753 constant 2022 US$ in Bolivia, Plurinational State of, a difference of 40 constant 2022 US$.
That makes Eritrea's figure about 1.1 times Bolivia, Plurinational State of's.
Across all 5 years both countries report, Eritrea has been ahead every year.
Bolivia, Plurinational State of ranks 65th and Eritrea ranks 62nd of 92 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,389 constant 2022 US$ | 2,666 constant 2022 US$ | 1,276 constant 2022 US$ | Eritrea |
| 2020s | 717.33 constant 2022 US$ | 2,245 constant 2022 US$ | 1,528 constant 2022 US$ | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Bolivia, Plurinational State of or Eritrea?
- Eritrea, at 793 constant 2022 US$ against 753 constant 2022 US$ in Bolivia, Plurinational State of as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Bolivia, Plurinational State of and Eritrea?
- 40 constant 2022 US$, with Eritrea ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Eritrea?
- 5 years are reported by both, from 2018 to 2024.
- How do Bolivia, Plurinational State of and Eritrea rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Bolivia, Plurinational State of ranks 65th and Eritrea ranks 62nd of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.